Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Chemoembolization for Lung Cancer and Metastases
NCT05672108Phase 2Recruiting
- Sponsor
- City of Hope
- Start
- May 2023
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mitomycin c in non-small cell lung cancer (NSCLC), lung metastases (LM), mediastinal neoplasm, pleural neoplasm, secondary malignant neoplasm of bronchus and lung, sponsored by City of Hope. Started May 2023; status: recruiting.
02
Drugs
mitomycin c
03
Conditions
non-small cell lung cancer (NSCLC)lung metastases (LM)mediastinal neoplasmpleural neoplasmsecondary malignant neoplasm of bronchus and lung
Beyond the preview
Go deeper on NCT05672108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672108.